DBV TECHNOLOGIES
NASDAQ: DBVT (DBV Technologies S.A.)
Kemas kini terakhir: 1 jam lalu12.35
-0.16 (-1.28%)
| Penutupan Terdahulu | 12.51 |
| Jumlah Dagangan | 137,640 |
| Harga / Buku (P/B) | 4.90 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -3,534.93% |
| EPS Cair (TTM) | -5.75 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -46.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 251.79% |
| Nisbah Semasa (MRQ) | 0.720 |
| Aliran Tunai Operasi (OCF TTM) | -89.45 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -53.08 M |
| Pulangan Atas Aset (ROA TTM) | -72.95% |
| Pulangan Atas Ekuiti (ROE TTM) | -198.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | DBV Technologies S.A. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.29 |
|
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Institusi | 1.81% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Mpm Bioimpact Llc | 30 Jun 2026 | 3,666,284 |
| Siren, L.L.C. | 30 Jun 2026 | 1,857,362 |
| Vivo Capital, Llc | 30 Jun 2026 | 1,844,758 |
| Perceptive Advisors Llc | 30 Jun 2026 | 1,653,350 |
| Baker Bros. Advisors Lp | 30 Jun 2026 | 1,461,425 |
| Artisan Partners Limited Partnership | 30 Jun 2026 | 1,372,851 |
| Logos Global Management Lp | 30 Jun 2026 | 915,000 |
| Patient Square Capital Lp | 30 Jun 2026 | 909,474 |
| Octagon Capital Advisors Lp | 30 Jun 2026 | 574,200 |
| Adar1 Capital Management, Llc | 30 Jun 2026 | 528,295 |
| Ikarian Capital, Llc | 30 Jun 2026 | 525,000 |
| Redmile Group, Llc | 30 Jun 2026 | 410,440 |
| Duquesne Family Office Llc | 30 Jun 2026 | 383,363 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |